Biomerica, Inc. (BMRA)
USD 0.54
(-5.4%)
USD 0.54
(-5.4%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 611 Thousand USD | 37.0% |
| 2023 | 446 Thousand USD | -85.02% |
| 2022 | 2.97 Million USD | 499.1% |
| 2021 | 496.98 Thousand USD | -72.11% |
| 2020 | 1.78 Million USD | 37.91% |
| 2019 | 1.29 Million USD | -26.36% |
| 2018 | 1.75 Million USD | -13.23% |
| 2017 | 2.02 Million USD | 32.66% |
| 2016 | 1.52 Million USD | -1.15% |
| 2015 | 1.54 Million USD | -7.63% |
| 2014 | 1.66 Million USD | -31.25% |
| 2013 | 2.42 Million USD | 5.69% |
| 2012 | 2.29 Million USD | 50.58% |
| 2011 | 1.52 Million USD | -2.25% |
| 2010 | 1.56 Million USD | -20.77% |
| 2009 | 1.96 Million USD | -7.76% |
| 2008 | 2.13 Million USD | -4.9% |
| 2007 | 2.24 Million USD | -6.64% |
| 2006 | 2.4 Million USD | -22.03% |
| 2005 | 3.08 Million USD | 5.78% |
| 2004 | 2.91 Million USD | 0.62% |
| 2003 | 2.89 Million USD | 14.31% |
| 2002 | 2.53 Million USD | -9.75% |
| 2001 | 2.8 Million USD | 6.77% |
| 2000 | 2.63 Million USD | -26.91% |
| 1999 | 3.6 Million USD | -12.2% |
| 1998 | 4.1 Million USD | 2.5% |
| 1997 | 4 Million USD | -9.09% |
| 1996 | 4.4 Million USD | 0.0% |
| 1995 | 4.4 Million USD | 10.0% |
| 1994 | 4 Million USD | 25.0% |
| 1993 | 3.2 Million USD | 6.67% |
| 1992 | 3 Million USD | -18.92% |
| 1991 | 3.7 Million USD | -11.9% |
| 1990 | 4.2 Million USD | 950.0% |
| 1989 | 400 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 325 Thousand USD | -21.12% |
| 2024 Q1 | 412 Thousand USD | 1330.21% |
| 2024 Q4 | 20 Thousand USD | 113.42% |
| 2024 Q3 | -149 Thousand USD | -145.85% |
| 2024 FY | 611 Thousand USD | 37.0% |
| 2023 FY | 446 Thousand USD | -85.02% |
| 2023 Q3 | 120.27 Thousand USD | -65.82% |
| 2023 Q1 | -54.95 Thousand USD | -108.84% |
| 2023 Q2 | 351.87 Thousand USD | 740.3% |
| 2023 Q4 | 28.8 Thousand USD | -76.05% |
| 2022 Q4 | 621.4 Thousand USD | -62.86% |
| 2022 Q1 | -88.97 Thousand USD | -901.24% |
| 2022 Q2 | 771.75 Thousand USD | 967.44% |
| 2022 Q3 | 1.67 Million USD | 116.81% |
| 2022 FY | 2.97 Million USD | 499.1% |
| 2021 FY | 496.98 Thousand USD | -72.11% |
| 2021 Q1 | 182.87 Thousand USD | -75.07% |
| 2021 Q3 | -38.5 Thousand USD | -110.65% |
| 2021 Q2 | 361.49 Thousand USD | 97.67% |
| 2021 Q4 | -8886.00 USD | 76.92% |
| 2020 Q1 | 367.3 Thousand USD | 103.15% |
| 2020 Q3 | 211.97 Thousand USD | -54.79% |
| 2020 Q2 | 468.87 Thousand USD | 27.65% |
| 2020 FY | 1.78 Million USD | 37.91% |
| 2020 Q4 | 733.62 Thousand USD | 246.08% |
| 2019 Q1 | 337.22 Thousand USD | 25.7% |
| 2019 Q2 | 408.06 Thousand USD | 21.01% |
| 2019 Q3 | 365.92 Thousand USD | -10.33% |
| 2019 Q4 | 180.8 Thousand USD | -50.59% |
| 2019 FY | 1.29 Million USD | -26.36% |
| 2018 Q2 | 506.19 Thousand USD | -1.63% |
| 2018 Q1 | 514.57 Thousand USD | 17.29% |
| 2018 Q3 | 465.37 Thousand USD | -8.06% |
| 2018 FY | 1.75 Million USD | -13.23% |
| 2018 Q4 | 268.26 Thousand USD | -42.35% |
| 2017 Q4 | 438.71 Thousand USD | -2.38% |
| 2017 Q1 | 576.96 Thousand USD | 66.72% |
| 2017 FY | 2.02 Million USD | 32.66% |
| 2017 Q2 | 556.68 Thousand USD | -3.51% |
| 2017 Q3 | 449.42 Thousand USD | -19.27% |
| 2016 Q2 | 412.04 Thousand USD | -2.23% |
| 2016 Q4 | 346.06 Thousand USD | 0.45% |
| 2016 Q1 | 421.42 Thousand USD | -9.53% |
| 2016 FY | 1.52 Million USD | -1.15% |
| 2016 Q3 | 344.51 Thousand USD | -16.39% |
| 2015 FY | 1.54 Million USD | -7.63% |
| 2015 Q3 | 458.83 Thousand USD | 49.34% |
| 2015 Q4 | 465.82 Thousand USD | 1.52% |
| 2015 Q1 | 309.91 Thousand USD | -46.08% |
| 2015 Q2 | 307.24 Thousand USD | -0.86% |
| 2014 Q1 | 260.29 Thousand USD | -45.89% |
| 2014 FY | 1.66 Million USD | -31.25% |
| 2014 Q3 | 578.56 Thousand USD | 126.32% |
| 2014 Q2 | 255.64 Thousand USD | -1.79% |
| 2014 Q4 | 574.71 Thousand USD | -0.67% |
| 2013 FY | 2.42 Million USD | 5.69% |
| 2013 Q4 | 481.01 Thousand USD | 8.0% |
| 2013 Q3 | 445.38 Thousand USD | -42.1% |
| 2013 Q2 | 769.21 Thousand USD | 5.05% |
| 2013 Q1 | 732.26 Thousand USD | 33.99% |
| 2012 Q2 | 667.4 Thousand USD | 29.24% |
| 2012 Q3 | 566.84 Thousand USD | -15.07% |
| 2012 Q4 | 546.5 Thousand USD | -3.59% |
| 2012 Q1 | 516.42 Thousand USD | 53.34% |
| 2012 FY | 2.29 Million USD | 50.58% |
| 2011 FY | 1.52 Million USD | -2.25% |
| 2011 Q3 | 499.47 Thousand USD | 66.19% |
| 2011 Q1 | 388.78 Thousand USD | -14.19% |
| 2011 Q2 | 300.54 Thousand USD | -22.7% |
| 2011 Q4 | 336.78 Thousand USD | -32.57% |
| 2010 Q4 | 453.08 Thousand USD | -11.98% |
| 2010 Q2 | 216.51 Thousand USD | -42.48% |
| 2010 FY | 1.56 Million USD | -20.77% |
| 2010 Q1 | 376.43 Thousand USD | -12.4% |
| 2010 Q3 | 514.72 Thousand USD | 137.73% |
| 2009 Q3 | 674.21 Thousand USD | 102.58% |
| 2009 Q4 | 429.7 Thousand USD | -36.27% |
| 2009 Q1 | 533.12 Thousand USD | -3.11% |
| 2009 Q2 | 332.81 Thousand USD | -37.57% |
| 2009 FY | 1.96 Million USD | -7.76% |
| 2008 Q4 | 550.23 Thousand USD | 11.58% |
| 2008 FY | 2.13 Million USD | -4.9% |
| 2008 Q2 | 486.34 Thousand USD | -19.54% |
| 2008 Q1 | 604.44 Thousand USD | -31.02% |
| 2008 Q3 | 493.11 Thousand USD | 1.39% |
| 2007 Q3 | 475.4 Thousand USD | -8.3% |
| 2007 Q1 | 375.65 Thousand USD | -26.17% |
| 2007 FY | 2.24 Million USD | -6.64% |
| 2007 Q4 | 876.23 Thousand USD | 84.31% |
| 2007 Q2 | 518.41 Thousand USD | 38.01% |
| 2006 Q3 | 348.6 Thousand USD | -56.73% |
| 2006 Q2 | 805.73 Thousand USD | 8.56% |
| 2006 Q1 | 742.2 Thousand USD | -13.23% |
| 2006 FY | 2.4 Million USD | -22.03% |
| 2006 Q4 | 508.83 Thousand USD | 45.96% |
| 2005 Q3 | 780.61 Thousand USD | 6.42% |
| 2005 FY | 3.08 Million USD | 5.78% |
| 2005 Q2 | 733.49 Thousand USD | 8.19% |
| 2005 Q1 | 677.94 Thousand USD | -15.43% |
| 2005 Q4 | 855.41 Thousand USD | 9.58% |
| 2004 Q3 | 818.43 Thousand USD | 24.24% |
| 2004 Q1 | 660.79 Thousand USD | -26.26% |
| 2004 FY | 2.91 Million USD | 0.62% |
| 2004 Q4 | 801.59 Thousand USD | -2.06% |
| 2004 Q2 | 658.73 Thousand USD | -0.31% |
| 2003 Q1 | 655.07 Thousand USD | 40.17% |
| 2003 FY | 2.89 Million USD | 14.31% |
| 2003 Q4 | 896.05 Thousand USD | 22.96% |
| 2003 Q3 | 728.71 Thousand USD | 17.8% |
| 2003 Q2 | 618.6 Thousand USD | -5.57% |
| 2002 Q3 | 812.15 Thousand USD | -0.47% |
| 2002 Q2 | 816.02 Thousand USD | 67.8% |
| 2002 Q1 | 486.31 Thousand USD | 14.84% |
| 2002 FY | 2.53 Million USD | -9.75% |
| 2002 Q4 | 467.34 Thousand USD | -42.46% |
| 2001 FY | 2.8 Million USD | 6.77% |
| 2001 Q1 | 715.93 Thousand USD | 5.2% |
| 2001 Q2 | 1.07 Million USD | 49.91% |
| 2001 Q3 | 596.93 Thousand USD | -44.38% |
| 2001 Q4 | 423.46 Thousand USD | -29.06% |
| 2000 Q4 | 680.54 Thousand USD | 13.86% |
| 2000 Q2 | 700 Thousand USD | 40.0% |
| 2000 Q1 | 500 Thousand USD | -58.33% |
| 2000 Q3 | 597.69 Thousand USD | -14.62% |
| 2000 FY | 2.63 Million USD | -26.91% |
| 1999 FY | 3.6 Million USD | -12.2% |
| 1999 Q1 | 900 Thousand USD | -18.18% |
| 1999 Q2 | 800 Thousand USD | -11.11% |
| 1999 Q3 | 700 Thousand USD | -12.5% |
| 1999 Q4 | 1.2 Million USD | 71.43% |
| 1998 Q1 | 1.1 Million USD | 22.22% |
| 1998 Q2 | 1.2 Million USD | 9.09% |
| 1998 Q4 | 1.1 Million USD | 22.22% |
| 1998 Q3 | 900 Thousand USD | -25.0% |
| 1998 FY | 4.1 Million USD | 2.5% |
| 1997 Q4 | 900 Thousand USD | 0.0% |
| 1997 FY | 4 Million USD | -9.09% |
| 1997 Q1 | 1.1 Million USD | -15.38% |
| 1997 Q2 | 1.1 Million USD | 0.0% |
| 1997 Q3 | 900 Thousand USD | -18.18% |
| 1996 FY | 4.4 Million USD | 0.0% |
| 1996 Q4 | 1.3 Million USD | 62.5% |
| 1996 Q1 | 1.1 Million USD | 0.0% |
| 1996 Q3 | 800 Thousand USD | -27.27% |
| 1996 Q2 | 1.1 Million USD | 0.0% |
| 1995 Q2 | 1.2 Million USD | 20.0% |
| 1995 FY | 4.4 Million USD | 10.0% |
| 1995 Q4 | 1.1 Million USD | 0.0% |
| 1995 Q3 | 1.1 Million USD | -8.33% |
| 1995 Q1 | 1 Million USD | -9.09% |
| 1994 Q4 | 1.1 Million USD | 22.22% |
| 1994 Q2 | 1 Million USD | 11.11% |
| 1994 Q3 | 900 Thousand USD | -10.0% |
| 1994 Q1 | 900 Thousand USD | 50.0% |
| 1994 FY | 4 Million USD | 25.0% |
| 1993 Q1 | 900 Thousand USD | 80.0% |
| 1993 FY | 3.2 Million USD | 6.67% |
| 1993 Q4 | 600 Thousand USD | -25.0% |
| 1993 Q3 | 800 Thousand USD | 0.0% |
| 1993 Q2 | 800 Thousand USD | -11.11% |
| 1992 Q3 | 600 Thousand USD | -25.0% |
| 1992 Q4 | 500 Thousand USD | -16.67% |
| 1992 Q1 | 1 Million USD | 0.0% |
| 1992 Q2 | 800 Thousand USD | -20.0% |
| 1992 FY | 3 Million USD | -18.92% |
| 1991 FY | 3.7 Million USD | -11.9% |
| 1991 Q1 | 1.3 Million USD | -66.67% |
| 1991 Q2 | 700 Thousand USD | -46.15% |
| 1991 Q3 | 700 Thousand USD | 0.0% |
| 1991 Q4 | 1 Million USD | 42.86% |
| 1990 Q1 | 100 Thousand USD | 200.0% |
| 1990 Q3 | 100 Thousand USD | -66.67% |
| 1990 Q2 | 300 Thousand USD | 200.0% |
| 1990 Q4 | 3.9 Million USD | 3800.0% |
| 1990 FY | 4.2 Million USD | 950.0% |
| 1989 Q3 | 200 Thousand USD | -33.33% |
| 1989 Q4 | -100 Thousand USD | -150.0% |
| 1989 FY | 400 Thousand USD | 0.0% |
| 1989 Q1 | 300 Thousand USD | 0.0% |
| 1989 Q2 | 300 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 119.477% |
| Cerus Corporation | 86.4 Million USD | 99.293% |
| OrthoPediatrics Corp. | 111.25 Million USD | 99.451% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | 17.38% |
| Talis Biomedical Corporation | 371 Thousand USD | -64.69% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 92.613% |
| Inogen, Inc. | 126.69 Million USD | 99.518% |
| Spectral AI, Inc. | 7.88 Million USD | 92.246% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 109.269% |
| CVRx, Inc. | 33.03 Million USD | 98.151% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -901.639% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.874% |
| Venus Concept Inc. | 52.16 Million USD | 98.829% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 76.039% |
| Bioventus Inc. | 328.19 Million USD | 99.814% |
| BrainsWay Ltd. | 23.09 Million USD | 97.354% |
| Envoy Medical, Inc. | -473 Thousand USD | 229.175% |
| electroCore, Inc. | 13.22 Million USD | 95.38% |
| IceCure Medical Ltd | 1.3 Million USD | 53.0% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 110.099% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 1390.772% |
| MaxCyte, Inc. | 36.54 Million USD | 98.328% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -33.839% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -618.316% |
| PAVmed Inc | -3.96 Million USD | 115.398% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 111.139% |
| RxSight, Inc. | 53.76 Million USD | 98.864% |
| Sight Sciences, Inc. | 69.17 Million USD | 99.117% |
| SI-BONE, Inc. | 109.42 Million USD | 99.442% |
| TELA Bio, Inc. | 40.11 Million USD | 98.477% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 96.159% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 99.598% |
| LivaNova PLC | 771.25 Million USD | 99.921% |
| 908 Devices Inc. | 25.32 Million USD | 97.587% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.803% |
| Nemaura Medical Inc. | -1.47 Million USD | 141.385% |
| NeuroPace, Inc. | 48.12 Million USD | 98.73% |
| LENSAR, Inc. | 21.1 Million USD | 97.105% |
| Apyx Medical Corporation | 14.12 Million USD | 95.673% |
| Cutera, Inc. | 41.49 Million USD | 98.527% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 96.69% |
| BioSig Technologies, Inc. | 18 Thousand USD | -3294.444% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 99.407% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 95.512% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.931% |
| Axonics, Inc. | 274.55 Million USD | 99.777% |
| Outset Medical, Inc. | 29 Million USD | 97.893% |
| IRIDEX Corporation | 21.8 Million USD | 97.198% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 99.14% |
| IRadimed Corporation | 50.15 Million USD | 98.782% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -112.892% |
| INVO Bioscience, Inc. | 1.08 Million USD | 43.746% |
| Telesis Bio, Inc. | 16.95 Million USD | 96.395% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 99.458% |
| Varex Imaging Corporation | 256.9 Million USD | 99.762% |
| Quipt Home Medical Corp. | 163.84 Million USD | 99.627% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 250.493% |
| Pulmonx Corporation | 50.75 Million USD | 98.796% |
| Dynatronics Corporation | 7.63 Million USD | 91.997% |
| Modular Medical, Inc. | -768 Thousand USD | 179.557% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 88.987% |
| Semler Scientific, Inc. | 61.2 Million USD | 99.002% |
| InMode Ltd. | 411.34 Million USD | 99.851% |
| Bruker Corporation | 1.51 Billion USD | 99.96% |
| Cytosorbents Corporation | 22.39 Million USD | 97.271% |
| DexCom, Inc. | 2.28 Billion USD | 99.973% |
| Align Technology, Inc. | 2.71 Billion USD | 99.978% |
| Viveve Medical, Inc. | 620 Thousand USD | 1.452% |
| ZimVie Inc. | 290.38 Million USD | 99.79% |
| Movano Inc. | -158 Thousand USD | 486.709% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 99.442% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -618.316% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.834% |
| Profound Medical Corp. | 4.51 Million USD | 86.464% |
| Insulet Corporation | 1.15 Billion USD | 99.947% |
| enVVeno Medical Corporation | -546 Thousand USD | 211.905% |
| Surmodics, Inc. | 93.05 Million USD | 99.343% |
| iCAD, Inc. | 14.53 Million USD | 95.797% |
| Nuwellis, Inc. | 4.98 Million USD | 87.738% |
| Biotricity, Inc. | 8.35 Million USD | 92.688% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.816% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 270.168% |
| InspireMD, Inc. | 1.8 Million USD | 66.187% |
| PAVmed Inc. | -3.96 Million USD | 115.398% |
| BIOLASE, Inc. | 16.72 Million USD | 96.347% |
| Beyond Air, Inc. | -1.3 Million USD | 146.748% |
| FONAR Corporation | 45.14 Million USD | 98.646% |
| AxoGen, Inc. | 127.87 Million USD | 99.522% |
| Vivani Medical, Inc. | -357 Thousand USD | 271.148% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.687% |
| Inari Medical, Inc. | 434.56 Million USD | 99.859% |
| UFP Technologies, Inc. | 112.22 Million USD | 99.456% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -4780.582% |
| Tenon Medical, Inc. | 1.24 Million USD | 50.766% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 854.321% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 76.742% |
| AdaptHealth Corp. | 479.56 Million USD | 99.873% |
| Sintx Technologies, Inc. | 1.84 Million USD | 66.848% |
| NanoVibronix, Inc. | 1.53 Million USD | 60.247% |
| Quanterix Corporation | 70.64 Million USD | 99.135% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 250.493% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 95.654% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 98.842% |
| TransMedics Group, Inc. | 154.09 Million USD | 99.603% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 86.279% |
| NeuroMetrix, Inc. | 3.94 Million USD | 84.522% |
| Hyperfine, Inc. | 4.75 Million USD | 87.156% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 99.429% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 98.534% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 178.238% |
| Silk Road Medical, Inc | 127.08 Million USD | 99.519% |